The Quinze-Vingts National Ophthalmology Hospital is France's national ophthalmology hospital located in Paris, in the 12th arrondissement. The hospital gave its name to the Quinze-Vingts quarter.

During the past decade, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 5 clinical trials were completed, i.e. on average, 12.2% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" #1 sponsor was "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" with 9 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Laboratoires Thea" with 4 trials sponsored, "Centre Hospitalier Intercommunal Creteil" with 3 trials sponsored and "GenSight Biologics" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" #1 collaborator was "Foundation Fighting Blindness" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Keyrus Biopharma" with 2 trials as a collaborator, "ADDMEDICA SASA" with 1 trials as a collaborator and "APHP" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" are "Retinitis Pigmentosa" (9 trials), "Geographic Atrophy" (6 trials), "Eye Diseases" (4 trials), "Glaucoma" (4 trials) and "Retinal Degeneration" (4 trials). Many other conditions were trialed in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" are "Drug" (18 trials), "Device" (16 trials), "Other" (12 trials), "Biological" (3 trials) and "Genetic" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Aflibercept" (2 trials), "Blephasteam" (2 trials), "GS010" (2 trials) and "Intelligent Retinal Implant System" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts" are 54 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts". undefined are not yet recruiting, 11 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".